Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
2018 · The Lancet · 1,223 citations
https://doi.org/10.1016/s0140-6736(18)32486-3
R
Ruth E. Langley
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
193
Papers
16.0K
Citations
42
h-index
87
i10-index
Ruth E. Langley is an academic researcher from MRC Clinical Trials Unit at UCL. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Prostate Cancer Treatment and Research & Esophageal Cancer Research and Treatment. The author has an h-index of 42, co-authored 165 publications.
ORCID: 0000-0002-9706-016XPapers by this author
worksDexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
2016 · The Lancet · 710 citations
https://doi.org/10.1016/s0140-6736(16)30825-x
Mismatch Repair Deficiency, Microsatellite Instability, and Survival
2017 · JAMA Oncology · 509 citations
https://doi.org/10.1001/jamaoncol.2016.6762
Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer
2019 · Journal of Clinical Oncology · 457 citations
https://doi.org/10.1200/jco.19.01124
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial
2016 · Journal of Clinical Oncology · 301 citations
https://doi.org/10.1200/jco.2015.65.7692
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus
2012 · Nature Genetics · 168 citations
https://doi.org/10.1038/ng.2408
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat